Short Term and Long Term Outcome for Elderly Patients Treated With Total Hip Replacement

NCT ID: NCT03120312

Last Updated: 2024-01-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-10-30

Study Completion Date

2024-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The is a retrospective analysis to study the characteristics of elderly patients treated with total hip replacements during past 5 years.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients underwent total hip replacement due to removal of the hip caused by retrogressive lesions, is conducive to the improvement of hip function .But at the same time,the complications from patients accepted total hip replacement surgery will directly or indirectly affect the prognosis of the patients, resulting in patients with delayed recovery and increase the hospitalization time and cost. Serious complications can lead to patients deaths during perioperative period. This study was designed to provide a retrospective analysis of postoperative recovery, quality of life, and complications in patients undergoing hip replacement over the past five years, providing data for clinical studies.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Total Hip Replacement

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

total hip replacement

primary hip replacement patients during past 5 years.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. ASA Ⅱ-Ⅲ,elective operation patients,
2. NO other severe complication history

Exclusion Criteria

1. Having severe comorbidity
2. not for the first time of joint replacement
3. Suffered from neurologic disorder or impaired mental state
Minimum Eligible Age

60 Years

Maximum Eligible Age

89 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Second Hospital of Shanxi Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Zheng Guo

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Zheng Guo

Role: STUDY_CHAIR

Second Hospital of Shanxi Medical University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Zheng Guo

Taiyuan, Shanxi, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Zheng Guo

Role: CONTACT

89351-3365790

Lili Wang

Role: CONTACT

15834058006

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Zheng Guo, MB,PhD

Role: primary

+863513365790

Weijun Liang, MSc

Role: backup

+863513365790

References

Explore related publications, articles, or registry entries linked to this study.

Penrod JD, Litke A, Hawkes WG, Magaziner J, Doucette JT, Koval KJ, Silberzweig SB, Egol KA, Siu AL. The association of race, gender, and comorbidity with mortality and function after hip fracture. J Gerontol A Biol Sci Med Sci. 2008 Aug;63(8):867-72. doi: 10.1093/gerona/63.8.867.

Reference Type BACKGROUND
PMID: 18772476 (View on PubMed)

Foss NB, Palm H, Krasheninnikoff M, Kehlet H, Gebuhr P. Impact of surgical complications on length of stay after hip fracture surgery. Injury. 2007 Jul;38(7):780-4. doi: 10.1016/j.injury.2006.08.028. Epub 2006 Oct 19.

Reference Type BACKGROUND
PMID: 17054955 (View on PubMed)

Singh JA, Jensen MR, Harmsen WS, Gabriel SE, Lewallen DG. Cardiac and thromboembolic complications and mortality in patients undergoing total hip and total knee arthroplasty. Ann Rheum Dis. 2011 Dec;70(12):2082-8. doi: 10.1136/ard.2010.148726. Epub 2011 Oct 21.

Reference Type BACKGROUND
PMID: 22021865 (View on PubMed)

Krecisz B, Kiec-Swierczynska M, Chomiczewska-Skora D. Allergy to orthopedic metal implants - a prospective study. Int J Occup Med Environ Health. 2012 Sep;25(4):463-9. doi: 10.2478/S13382-012-0029-3. Epub 2012 Dec 3.

Reference Type BACKGROUND
PMID: 23212287 (View on PubMed)

Deutman R, Mulder TJ, Brian R, Nater JP. Metal sensitivity before and after total hip arthroplasty. J Bone Joint Surg Am. 1977 Oct;59(7):862-5.

Reference Type BACKGROUND
PMID: 908716 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ZGuo

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.